Amplify Therapeutics ApS

CVR number: 43803999
Ole Maaløes Vej 3, 2200 København N

Income statement (kDKK)

2023
Fiscal period length12
Net sales
Gross profit-1 558.70
Employee benefit expenses- 825.44
EBIT-2 384.14
Other financial income2.80
Other financial expenses-97.70
Pre-tax profit-2 479.04
Income taxes526.32
Net earnings-1 952.72

Assets (kDKK)

2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables278.46
Current deferred tax assets526.32
Short term receivables total804.79
Cash and bank deposits1 824.90
Cash and cash equivalents1 824.90
Balance sheet total (assets)2 629.68

Equity and liabilities (kDKK)

2023
Share capital40.00
Profit of the financial year-1 952.72
Shareholders equity total-1 912.72
Non-current deferred tax liabilities4 097.64
Non-current liabilities total4 097.64
Current trade creditors257.08
Other non-interest bearing current liabilities121.02
Accruals and deferred income66.67
Current liabilities total444.76
Balance sheet total (liabilities)2 629.68
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.